Medtronic today announced it has completed its acquisition of Scientia Vascular.
The acquisition is valued at US$550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition, according to a Medtronic press release.
Scientia has developed “best-in-class” access products that enable simplicity and access for physicians treating complex neurovascular conditions—and the company’s portfolio of guidewires and catheters can be “seamlessly” integrated with Medtronic’s existing suite of neurovascular products, strengthening the company’s ability to support physicians across the full procedural workflow.
“Since its founding, Scientia has been driven by a commitment to improving patients’ lives and supporting the physicians who care for them,” said Rick Randall, chief executive officer (CEO) of Scientia. “Joining Medtronic is an exciting next step for our team, as their mission closely aligns with the values that have guided Scientia from the beginning. With Medtronic’s global scale, we look forward to bringing this technology to more physicians and reaching more patients around the world.”
“The addition of Scientia’s access technologies strengthens our ability to simplify complex neurovascular procedures and support physicians with more seamless solutions,” added Linnea Burman, senior vice president and president of Medtronic’s neurovascular business. “By bringing together highly complementary technologies, we are building a more integrated platform that will help advance the future of neurovascular care, and enable physicians to treat more patients with greater efficiency and confidence.”
